Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset

Synapse

Volumn 26, Issue 3, 1997, Pages 301-316

  Mackenzie, G M ^a   Jackson, M J ^a   Jenner, P ^a   Marsden, C D ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; L N(G) nitro arginine methyl ester; nitric oxide; nitric oxide synthase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; GLIAL FIBRILLARY ACIDIC PROTEIN; MAZINDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; CAUDATE NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MARMOSET; MOTOR DYSFUNCTION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA; TOXICITY;

EID: 0031003702     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199707)26:3<301::AID-SYN11>3.0.CO;2-Y     Document Type: Article

References (38)

1. Bredt, D.S., and Snyder, S.H. (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A., 87:682-685.
2. Brouillet, E., and Beal, M.F. (1993) NMDA antagonists partially protect against MPTP induced neurotoxicity in mice. NeuroReport, 4:387-390.
3. +) Neurosci. Lett., 117:129-133.
4. Dawson, T.M., Dawson, V.L., and Snyder, S.H. (1992) A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol., 32:297-311.
5. Drapier, J.-C., and Hibbs, J.B. Jr. (1988) Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol., 140:2829-2838.
6. Gnanalingham, K.K., Smith, L.A., Hunter, A.J., Jenner, P., and Marsden, C.D. (1993) Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: An autoradiographic study. Synapse, 14:184-194.
7. Hantraye, P., Brouillet, E., Ferrante, R., Palfi, S, Dolan, R., Matthews, R.T., and Beal, M.F. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med., 2:1017-1021.
8. Harik, S.I., Schmidley, J.W., Iacofano, L.A., Blue, P., Arora, P.K., and Sayre, L.M. (1987) On the mechanisms underlying 1-methy-4-phenyl-1,2,3,4-tetrahydropyridine neurotoxicity: The effects of perinigral infusion of 1-methy-4-phenyl-1,2,3,4-tetrahydropyridine, its metabolite and their analogues in the rat. J. Pharmacol. Exp. Ther., 241:669-676.
9. Heikkila, R.E., Hess, A., and Duvoisin, R.C. (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monamine oxidase, MPTP metabolism and neurotoxicity. Life Sci., 36:231-236.
10. Javitch, J.A., Strittmatter, S.M., and Snyder, S.H. (1985) Differential visualisation of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography. J. Neurosci., 5:1513-1521.
11. Jenner, P., Rose, S., Boyce, S., Kelly, E., Kilpatrick, G., Rupniak, N.M.J., Briggs, R., and Marsden, C.D. (1986) Induction of parkinsonism in the common marmoset by administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. In: Recent Developments in Parkinson's Disease. S. Fahn et al., eds. Raven Press, New York, pp. 137-146.
12. Kelly, P.A.T., Ritchie, I.M., and Arbuthnott, G.W. (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole: Effects upon local cerebral blood flow and glucose use in the rat. J. Cereb. Blood Flow Metab., 15:766-773.
13. Knowles, R.G., and Moncada, S. (1994) Nitric oxide synthases in mammals. Biochem. J., 298:249-258.
14. Kovach, A.G.B., Lohinai, Z., Marczis, J., Balla, I., Dawson, T.M. and Snyder, S.H. (1994) The effect of hemorrhagic hypotension and retransfusion and 7-nitro indazole on rCBF, NOS catalytic activity and cortical NO content in the cat. IBC's 3rd symposium on nitric oxide. Advances in therapeutic application and commercial development. The Ritz-Carlton, Philadelphia.
15. Kupsch, A., Löschmann, P-A., Sauer, H., Arnold, G., Renner, P., Pufal, D., Burg, M., Wachtel, H., ten Bruggencate, G., and Oertel, W.H. (1992) Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice. Brain Res., 592:74-83.
16. Langston, J.W., Forno, L.S., Rebert, C.S., and Irwin, I. (1984) Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res., 292:390-394.
17. MacKenzie, G.M., Jenner, P., and Marsden, C.D. (1995) The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum. Neuroscience, 67:357-371.
18. MacKenzie, G.M., Rose, S., Bland-Ward, P.A., Moore, P.K., Jenner, P., and Marsden, C.D. (1994) Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. NeuroReport 5:1993-1996.
19. Mizuno, Y., Saitoh, T., and Sone, N. (1987) Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion. Biochem. Biophys. Res. Commun., 143:971-976.
20. Moore, P.K., Wallace, P., Gaffen, Z.A., Hart, S.L., and Babbedge, R.C. (1993) Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br. J. Pharmacol., 110:219-224.
21. Nicklas, W.J., Vyas, I., and Heikkila, R.E. (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci., 36:2503-2505.
22. Pearce, R.K.B., Jackson, M., Smith, L., Jenner, P., and Marsden, C.D. (1995) Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix jacchus). Movement Dis., 10:731-740.
23. Przedborski, S., Jackson-Lewis, V., Yokoyama, R., Shibata, T., Dawson, V.L., and Dawson, T.M. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. U.S.A., 93:4565-4571.
24. Riveros-Moreno, V., Beddell, C., and Moncada, S. (1993) Nitric oxide synthase. Structural studies using anti-peptide antibodies. Eur. J. Biochem., 215:801-808.
25. Santiago, M., Machado, A., and Cano, J. (1994) Effect of L-arginine/ nitric oxide pathway on MPP -induced cell injury in the striatum of rats. Br. J. Pharmacol., 111:837-842.
26. + neurotoxicity by N-methyl-D-aspartate antagonists. Brain Res., 586:203-207.
27. Schmidt, W., Wolf, G., Calka, J., and Schmidt, H.H.H.W. (1995) Evidence for bidirectional changes in nitric oxide synthase activity in the rat striatum after excitotoxically (quinolinic acid) induced degeneration. Neuroscience, 67:345-356.
28. Schulz, J.B., Matthews, R.T., Muqit, M.M.K., Browne, S.E., and Beal, M.F. (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroin-dazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem., 64:936-939.
29. Sonsalla, P.K., Zeevalk, G.D., Manzino, L., Giovanni, A., and Nicklas, W.J. (1992) MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenypyridinium in rats. J. Neurochem., 58:1979-1983.
30. +-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase. NeuroReport, 5:2598-2600.
31. Starr, M.S., and Starr, B.S. (1995) Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide? Eur. J. Pharmacol., 272:211-217.
32. Stephan, H., Baron, G., and Schwerdtfeger, W.K. (1980) The brain of the common marmoset. In: A Stereotaxic Atlas. Springer-Verlag, Germany.
33. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature, 349:414-418.
34. Vincent, S.R., and Kimura, K. (1992) Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience, 46:755-784.
35. Wallace, M.N., and Bisland, S.K. (1995) NADPH diaphorase activity in activated astrocytes represents inducible nitric oxide synthase. Neuroscience, 59:905-919.
36. Willis, G.L., and Donnan, G.A. (1987) Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice. Brain Res., 402:269-274.
37. Zeevalk, G.D., Nicklas, W.J., and Sonsalla, P.K. (1994) NMDA receptor involvement in two animal models of Parkinson's disease. Neurobiol. Aging, 15:269-270.
38. Zuddas, A., Oberto, G., Vaglini, F., Fascetti, F., Fornai, F., and Corsini, G.U. (1992) MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. J. Neurochem., 59:733-739.